The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582
- PMID: 1645340
The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582
Abstract
L-651,582, 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4- carboxamide, an antiproliferative and antiparasitic agent previously shown to affect 45Ca2+ uptake into mammalian cells, inhibits both receptor-mediated and voltage-dependent calcium entry in well characterized in vitro systems. Indo 1 fluorescence measurements of cytosolic calcium levels indicate that the drug has no effect on the initial transient release of internal stores of calcium stimulated by fMet-Leu-Phe in rat polymorphonuclear leukocytes. It does decrease the levels maintained subsequently, however, indicating blockage of calcium influx through receptor-operated channels. L-651,582 also blocks the stimulation of leukotriene B4 (LTB4) production by fMet-Leu-Phe with an IC50 = 0.5 micrograms/ml equal to that for calcium entry inhibition. The LTB4 inhibition is likely due to calcium entry inhibition since L-651,582 does not inhibit calmodulin or enzymes producing arachidonate metabolites. L-651,582 also inhibits potassium-stimulated 45Ca2+ influx into GH3 cells with an IC50 of 0.5 microgram/ml, indicating a block of voltage-gated L-type calcium channels. Patch voltage clamp measurements of current through L- and T-type calcium in guinea pig atrial cells also indicate that L-651,582 is a calcium antagonist. Block of L-type calcium channels is voltage-dependent, and the apparent dissociation constant for the high affinity state is 0.2 micrograms/ml. The IC50 for block of T-type calcium channels is 1.4 micrograms/ml. The inhibition of cellular proliferation and the production of arachidonate metabolites by L-651,582 may be the result of the nearly equipotent block of receptor-operated and voltage-gated calcium channels.
Similar articles
-
Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.Mol Pharmacol. 1986 Nov;30(5):437-43. Mol Pharmacol. 1986. PMID: 2430168
-
The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.J Pharmacol Exp Ther. 1991 Jun;257(3):967-71. J Pharmacol Exp Ther. 1991. PMID: 1646332
-
SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.Biochem J. 1990 Oct 15;271(2):515-22. doi: 10.1042/bj2710515. Biochem J. 1990. PMID: 2173565 Free PMC article.
-
Store-Independent Orai Channels Regulated by STIM.In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 11. In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 11. PMID: 30299650 Free Books & Documents. Review.
-
Voltage-dependent calcium channels.Gen Physiol Biophys. 2005 Jun;24 Suppl 1:1-78. Gen Physiol Biophys. 2005. PMID: 16096350 Review.
Cited by
-
Calcium signalling pathways in prostate cancer initiation and progression.Nat Rev Urol. 2023 Sep;20(9):524-543. doi: 10.1038/s41585-023-00738-x. Epub 2023 Mar 24. Nat Rev Urol. 2023. PMID: 36964408 Review.
-
Rce1: mechanism and inhibition.Crit Rev Biochem Mol Biol. 2018 Apr;53(2):157-174. doi: 10.1080/10409238.2018.1431606. Epub 2018 Feb 9. Crit Rev Biochem Mol Biol. 2018. PMID: 29424242 Free PMC article. Review.
-
One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists.Bioorg Med Chem Lett. 2019 Dec 1;29(23):126707. doi: 10.1016/j.bmcl.2019.126707. Epub 2019 Sep 16. Bioorg Med Chem Lett. 2019. PMID: 31630858 Free PMC article.
-
Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity.Sci Pharm. 2013 Apr 14;81(3):663-76. doi: 10.3797/scipharm.1302-04. Print 2013 Jul-Sep. Sci Pharm. 2013. PMID: 24106665 Free PMC article.
-
ORAI1 Ca2+ Channel as a Therapeutic Target in Pathological Vascular Remodelling.Front Cell Dev Biol. 2021 Apr 6;9:653812. doi: 10.3389/fcell.2021.653812. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33937254 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials